Zydus Lifesciences net profit up 14% on strong India, US formulations biz

Q: How long will it take to read this news story?

The story "Zydus Lifesciences net profit up 14% on strong India, US formulations biz" has 478 words across 19 sentences, which will take approximately 2 - 4 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Zydus Lifesciences net profit up 14% on strong India, US formulations biz" was covered 21 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 297 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #23554895</li><li>URL: https://beamstart.com/news/zydus-lifesciences-net-profit-up-17314206365187</li></ul>

Business Standard Logo Business Standard 21h ago

Zydus Lifesciences net profit up 14% on strong India, US formulations biz - Business Standard

Quick Summary:

On Tuesday, Zydus Lifesciences shares fell by 1.90 per cent, closing at Rs 950.10 apiece on the Bombay Stock Exchange (BSE).

The growth is attributed to strong performances across domestic and international formulations, and double-digit growth in the consumer wellness business.

The company stated that its branded formulations business outperformed the market in both chronic and acute segments, driven by strong volume growth of core and innovative products.